ATHA
Athira Pharma, Inc. (ATHA) ESG Analysis Analysis (2026)
No material changes this month.
Environmental
No disclosed environmental operating metrics in the provided data limit peer-relative assessment, leaving ATHA neither clearly advantaged nor disadvantaged versus similarly reported peers.
Zero reported R&D intensity suggests limited disclosure on low-carbon or resource-efficiency initiatives, which is weaker than peers with explicit transition investment visibility.
The absence of gross margin and FCF margin data prevents evaluating environmental cost exposure, so ATHA’s environmental positioning remains largely disclosure-constrained relative to peers.
Low leverage does not directly indicate environmental strength, but it can reduce balance-sheet pressure to fund remediation or transition spending compared with more indebted peers.
Social
No workforce, safety, turnover, or community metrics are provided, so ATHA cannot be credited with the stronger social transparency seen at better-disclosed peers.
Zero stock-based compensation to revenue may indicate limited equity dilution pressure, but it does not by itself demonstrate stronger employee alignment than peers.
The lack of R&D spend disclosure limits assessment of human-capital investment intensity, leaving ATHA’s social profile broadly neutral versus peers.
Missing operating and margin data also restricts inference on labor resilience and stakeholder treatment, keeping the social score near the peer median.
Governance
Very low debt-to-equity and net debt-to-EBITDA suggest conservative capital structure, which generally lowers creditor pressure and governance risk versus more leveraged peers.
Zero stock-based compensation to revenue is a positive governance signal because it reduces dilution and may indicate less aggressive executive incentive design than peers.
However, the absence of board, audit, ownership, and controversy data prevents a stronger governance assessment, limiting ATHA’s relative score.
Overall governance appears somewhat better than average on capital discipline, but insufficient disclosure keeps it below clearly leading peer groups.
Overall Score
ATHA’s ESG profile is constrained by sparse disclosure, with modest governance advantages from low leverage offset by limited evidence of stronger environmental or social practices versus peers.
Score Driver: Conservative Leverage And Low Compensation Intensity Are The Main Relative Positives, But Incomplete ESG Disclosure Prevents A Stronger Peer Ranking.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Athira Pharma, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.
